Pimavanserine API is a selective serotonin 5-HT₂A receptor inverse agonist used for the treatment of Parkinson’s disease psychosis. It works by modulating serotonergic signaling without significant dopamine receptor blockade, reducing hallucinations and delusions. Pimavanserine API is produced under GMP-compliant conditions and is suitable for oral tablet formulations.

Pimavanserine API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.